March 23, 2011
A Delaware federal court on Wednesday allowed Abbott Laboratories and the Wisconsin Alumni Research Foundation to drop their patent infringement case seeking to stop Anchen Pharmaceuticals Inc. from taking steps to launch a generic version of kidney disease treatment Zemplar.